The FDA is asking for MOA and batch consistancy data to put a halt to the cowboy outfits that will seek to copy MSB.
This will form a big moat for MSB once done.
Yes it may also be a delaying tactic which enriches big pharma meanwhile but at least there is some legitimacy to the arguments used.
The clock is ticking on that however and in a few months time the FDA will be out of excuses.
Rem-L Needed NOW, page-4
-
- There are more pages in this discussion • 176 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |